Navigation Links
VisEn Launches New OsteoSense(R) 800 and VivoTag(R) 800 Fluorescence Molecular Imaging Agents
Date:11/19/2009

BEDFORD, Mass., Nov. 19 /PRNewswire/ -- VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new OsteoSense® 800 imaging agent for targeting areas of bone turnover and microcalcification in vivo. The new 800 nm OsteoSense agent complements VisEn's OsteoSense 680 and 750 products, and is expected to further expand the utilization of this agent family in enabling in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis. In addition, VisEn has launched a new near infrared label, VivoTag 800® to add an additional wavelength channel to its current line of VivoTag fluorochromes which are used to label specific ligands of interest in a wide variety of in vivo and in vitro imaging applications. Both of the new 800 nm agents are well suited for imaging quantification on the VisEn FMT 2500(TM) LX quantitative tomography imaging system, which also has expanded wavelength capabilities to enable simultaneous imaging of up to four agents and biologies of interest in vivo.

VisEn's proprietary fluorescence imaging agents and labels are designed to provide the industry's broadest and most robust range of biologically-specific imaging readouts in vivo. VisEn now offers over 30+ different fluorescence molecular agents for imaging key disease-associated biologic targets, processes and pathways. VisEn agent brands include ProSense®, IntegriSense(TM), AngioSense(TM), OsteoSense®, Annexin-Vivo(TM), MMPSense(TM), Cat B FAST(TM), Cat K FAST(TM) and ReninSense(TM) FAST. VisEn also offers its specialized in vivo agent labeling platforms, including its proprietary VivoTag® fluorescence labeling dyes for custom agent development, and its NanoSpark
'/>"/>

SOURCE VisEn Medical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. VisEn Launches New Cat B 750 Fast(TM) Fluorescence Molecular Imaging Agent at American Heart Association Meeting
2. VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
3. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
4. TRACE Launches Compendium
5. Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool
6. CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms
7. Custom Spine Launches Pathway AVID and Regent ACP at NASS
8. Xanodyne Expands U.S. Sales Force and Launches Zipsor(TM) (diclofenac potassium) Liquid Filled Capsules
9. Cardio Vascular Medical Device Launches Corporate Website
10. Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII
11. Deloitte Recap Launches New Solution for Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2010)... Matrixx Initiatives, Inc. (Nasdaq: MTXX ), an over-the-counter ... first quarter ended June 30, 2010 , will be released ... An earnings conference call will be held the following morning on ... . , , , ... access the teleconference, please call (888) 287-5536 (domestic) or (719) 325-2332 ...
(Date:7/28/2010)... DURECT Corporation (Nasdaq: DRRX ) announced today that ... Capital Markets 10th Annual Focus on Healthcare Conference on Thursday, August 5 ... at the Sheraton New York Hotel.   , ... (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO ) , , ... http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) , , , ...
(Date:7/28/2010)... , July 28 Dr. Michael Klein , ... how FDA works with other entities to confront and to prevent misuse ... , , ... , , ... , , ...
Breaking Medicine Technology:Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 First Quarter Financial Results 2DURECT to Present at the BMO Capital Markets Focus on Healthcare Conference 2FDA CONSUMER HEALTH INFORMATION - Combating Misuse and Abuse of Prescription Drugs: Q&A with Michael Klein, Ph.D. 2Information about the use and accuracy of breast cancer tests is lacking study finds 56994 1Information about the use and accuracy of breast cancer tests is lacking study finds 56994 2Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 1Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 2Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 3Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 4Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 5Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug Drug Interaction Profile for NKTR 118 4985 6Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 1Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 2Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 3Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 4Two New Studies Report Increased Survival Rates in Tamiflu 28R 29 Treated Patients with Avian Flu 28H5N1 29 and Severe Seasonal Flu 4983 5
(Date:7/29/2010)... HealthDay Reporter , , THURSDAY, July 29 (HealthDay News) -- ... a better predictor of how well a woman will ... been the traditional way of looking at cancers, new ... the genetic makeup of 595 breast cancer tumors and ... used algorithms to separate the tumors into eight types ...
(Date:7/29/2010)... Administration (FDA) received reports of malignancies in children using ... an associated risk and prompting an investigation. Researchers from ... malignancy in children using infliximab, etanercept, and adalimumab and ... Arthritis & Rheumatism , a journal of the ... approved 3 TNF blockers for use in children: Etanercept ...
(Date:7/29/2010)... , , THURSDAY, July 29 (HealthDay News) -- New research ... the risk of broken bones in postmenopausal women with ... risk seen among men who had been prescribed either ... isn,t the first time such an association has been ... belong to the class of medications known as thiazolidinediones ...
(Date:7/29/2010)... history of male breast cancer perceive themselves to be at ... a family history of female breast cancer; however those with ... know about or seek genetic testing than those with a ... led by researchers at the University of Louisville,s James Graham ... accounts for only about one percent of all breast cancers, ...
(Date:7/29/2010)... new study from Perth,s Telethon Institute for Child Health ... diet in adolescents. , The research findings have just ... Attention Disorders . , Leader of Nutrition studies at ... examined the dietary patterns of 1800 adolescents from the ... ,Western, patterns. , "We found a diet high ...
Breaking Medicine News(10 mins):Health News:Breast Cancer's DNA Yields More Secrets 2Health News:Breast Cancer's DNA Yields More Secrets 3Health News:TNF blockers may increase the risk of malignancy in children 2Health News:TNF blockers may increase the risk of malignancy in children 3Health News:New Data Supports Link Between Diabetes Drugs, Fractures 2Health News:New Data Supports Link Between Diabetes Drugs, Fractures 3Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 2Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 3Health News:Western diet link to ADHD 2
... June 15, 2006 issue of CANCER, a peer-reviewed journal ... radiation// could be a treatment option for men aged ... ,Age has remained a controversial factor, which dictates ... recommend more aggressive therapy as compared to older individuals. ...
... is a generally accepted fact that the doses given ... it is not always clear, how much is enough ... Children’s Center shows that making the dosage a computerized ... well. ,An online infusion calculator and a ...
... leading cardinal has urged Christians to initiate legal action against ... he feels that it offends Christ// and the Church as ... it is enough for us to forgive and to forget,' ... attempts to disclose a murder mystery associated with the life ...
... remembered of the 90 million odd volunteers belonging to the ... back bone of the movement//, and whose helping hand is ... needy all over the world. , ,These unsung heroes ... risking their lives at times, in order to help others ...
... die every day in Madhya Pradesh due to pregnancy related complications, ... ,According to data from the National Family Health Survey (NFHS), the ... which means that out of every 100,000 women, 498 die either ... mother. ,Taking the Census figures, about 1.9 million ...
... apply for a separate insurance scheme as they would no ... may feel that they can go without insurance to save ... or diagnosed with a serious medical problem. Even those ... a few months since there's often a waiting period before ...
Other Medicine News:Health News:Dispensing Drug Dosage To Children Through Computers 2Health News:Dispensing Drug Dosage To Children Through Computers 3Health News:Dispensing Drug Dosage To Children Through Computers 4Health News:Salutations For The Selfless Heroes On World Red Cross Day 2Health News:At Least 25 Women Die Of Maternity Complications In MP Everyday 2Health News:Insurance Plans after Graduation 2
Eschenbach's new 2636 series of stand magnifiers delivers the benefits of high power and a large fields of view. Using a unique doublet lens design, the 2636 offers the highest power recatngular lens...
The Multi-Purpose Stand Magnifier is the most versatile stand magnifier. The stand has multiple configurations allowing for all situations where hands-free magnification is needed....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Bausch & Lomb round and rectangular magnifiers incorporate precision optics and an ergonomic design for increased clarity and comfort during use...
Medicine Products: